Key Takeaways Semaglutide, Tirzepatide, and Retatrutide are GLP-1 (glucagon-like peptide-1) medications, each offering increasing efficacy through multi-receptor targeting
For the vast majority of people, the minor inconvenience of measuring doses from vials is a worthwhile trade-off for 80% cost savings
These medications are appropriate when their benefits outweigh their risks, says Charlie Seltzer, MD , a board-certified obesity medicine doctor in Philadelphia
While constipation is common with GLP-1 agonists, it should respond to standard remedies
If you have any questions during this time, you can reach the Prior Authorizations team directly by responding to the message titled PRIOR AUTH SUBMISSION or contact your pharmacy benefit plan directly